These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
550 related items for PubMed ID: 16776932
1. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention]. He B, Ding S, Pu J, Liu JP, Song W, Du YP, Shen JY, Jin SX, Sun Y, Shen L. Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932 [Abstract] [Full Text] [Related]
2. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome]. Sun YH, Wang GL, Fu YY, Xue C, Hu DY. Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924 [Abstract] [Full Text] [Related]
3. Use of B-type natriuretic peptide in evaluation of early percutaneous coronary intervention in patients with acute coronary syndrome. Jiang CY, Li N, Wang JA. Chin Med J (Engl); 2004 Aug; 117(8):1130-4. PubMed ID: 15361283 [Abstract] [Full Text] [Related]
4. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651 [Abstract] [Full Text] [Related]
5. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome. Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK. Indian Heart J; 2008 Aug; 60(6):536-42. PubMed ID: 19276492 [Abstract] [Full Text] [Related]
6. Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. de Winter RJ, Stroobants A, Koch KT, Bax M, Schotborgh CE, Mulder KJ, Sanders GT, van Straalen JP, Fischer J, Tijssen JG, Piek JJ. Am J Cardiol; 2004 Dec 15; 94(12):1481-5. PubMed ID: 15589000 [Abstract] [Full Text] [Related]
10. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Ang DS, Kong CF, Kao MP, Struthers AD. Am Heart J; 2009 Jul 15; 158(1):133-40. PubMed ID: 19540403 [Abstract] [Full Text] [Related]
11. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department. Bassan R, Tura BR, Maisel AS. Coron Artery Dis; 2009 Mar 15; 20(2):143-9. PubMed ID: 19293713 [Abstract] [Full Text] [Related]
12. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions. Liu T, Xie Y, Zhou YJ, Li YP, Ma HY, Guo YH, Liu YY, Zhao YX, Shi DM. Chin Med J (Engl); 2009 Aug 05; 122(15):1732-7. PubMed ID: 19781316 [Abstract] [Full Text] [Related]
13. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up. Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A. Nephron Clin Pract; 2011 Aug 05; 119(2):c162-70. PubMed ID: 21757955 [Abstract] [Full Text] [Related]
14. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Kuklinska AM, Sobkowicz B, Mroczko B, Sawicki R, Musial WJ, Knapp M, Dobrzycki S, Szmitkowski M. Clin Chim Acta; 2007 Jul 05; 382(1-2):106-11. PubMed ID: 17482153 [Abstract] [Full Text] [Related]
15. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients]. Li ZH, Xiao J, Li JZ. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar 05; 23(3):179-82. PubMed ID: 21366951 [Abstract] [Full Text] [Related]
16. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction]. Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT. Pol Merkur Lekarski; 2010 Jun 05; 28(168):444-9. PubMed ID: 20642101 [Abstract] [Full Text] [Related]
17. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention. Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S. Coron Artery Dis; 2010 Aug 05; 21(5):261-5. PubMed ID: 20555264 [Abstract] [Full Text] [Related]
18. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Ivanes F, Susen S, Mouquet F, Pigny P, Cuilleret F, Sautière K, Collet JP, Beygui F, Hennache B, Ennezat PV, Juthier F, Richard F, Dallongeville J, Hillaert MA, Doevendans PA, Jude B, Bertrand M, Montalescot G, Van Belle E. Eur Heart J; 2012 Jan 05; 33(2):191-202. PubMed ID: 21719456 [Abstract] [Full Text] [Related]
19. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Montaner J, García-Berrocoso T, Mendioroz M, Palacios M, Perea-Gainza M, Delgado P, Rosell A, Slevin M, Ribó M, Molina CA, Alvarez-Sabín J. Cerebrovasc Dis; 2012 Jan 05; 34(3):240-5. PubMed ID: 23018289 [Abstract] [Full Text] [Related]
20. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Karha J, Bavry AA, Rajagopal V, Henderson MR, Ellis SG, Brener SJ. Am J Cardiol; 2006 Sep 01; 98(5):616-8. PubMed ID: 16923447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]